Alvarez & Marsal recently hosted an engaging and practical session tailored for tax, finance, and trade professionals in the pharmaceutical industry. This first edition of our Thailand Tax Talk: Industry Series explored how tax leaders in the pharma sector can respond to increasing regulatory pressure, operational complexity, and cross-border trade disruption.
Download the Presentation
Explore transfer pricing challenges in the pharmaceutical sector, shaped by high profitability, R&D investments, patent protections, and marketing intangibles.
A&M Tax Talks: Tax Policy Updates
June 11, 2026
The Tax Policy and Controversy (TPC) group at A&M Tax brings forward expert perspectives on the key developments shaping global tax policy.
OECD’s Proposed Revisions to Chapter VII: Reframing the Transfer Pricing Analysis of Intra-Group Services
June 11, 2026
Transfer Pricing Update: OECD Chapter VII proposes revised guidance on intra-group services, accurate delineation, benefit test, method selection, and documentation.
Insurance Industry Taxation Is Approaching an Inflection Point – Beyond Compliance Lies a Strategic Function
June 10, 2026
Insurance tax functions are moving beyond compliance toward a more strategic role. Learn how Alvarez & Marsal helps insurers combine tax planning, technical judgment, and operational efficiency.
Singapore transfer pricing alert: IRAS clarifies SBC treatment for cost-plus service providers from YA 2026
June 10, 2026
Singapore Transfer Pricing Update: IRAS clarifies SBC for cost-plus/TNMM service providers; YA 2026 concession on uncharged and notional SBC.
